About UsProductsInvestor RelationsPress ReleasesContact Us
June 19, 2014

Merus Labs International Inc. Announces Closing of $31.3 Million Bought Deal Financing, Including Exercise of Over-Allotment Option
June 16, 2014

Merus to Present at Bloom Burton & Co. Healthcare Investor Conference
June 12, 2014

Merus Labs International Inc. Announces Increase to Previously Announced Financing
June 11, 2014

Merus Labs International Inc. Announces $22.1 Million Bought Deal Financing
June 10, 2014

Merus Labs International Inc. Announces Aggregate $21 Million Financing Transactions
ENABLEX®/ EMSELEX®
Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of overactive bladder: a strong need to urinate with leaking or wetting accidents (urge urinary incontinence), a strong need to urinate right away (urgency), and having to urinate often (urinary frequency)... [more]
VANCOCIN® capsules
Clostridium difficile infection (CDI) causes watery or mucousy diarrhea, lower abdominal pain and systemic symptoms such as fever, anorexia, nausea and malaise when mildly symptomatic, and life-threatening toxic megacolon when severe... [more]

Symbol: MSLI
Last:
Change:
Date:
Time:
Symbol: MSL
Last:
Change:
Date:
Time:
Quotes are delayed at least 15 minutes.
Get latest news from Merus Labs via e-mail.
Subscribe
Unsubscribe
Submit

Copyright © 2012 Merus Labs Inc. All Rights Reserved.